Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma
NRG Oncology
NRG Oncology
Institut Claudius Regaud
Stichting Hemato-Oncologie voor Volwassenen Nederland
Rezolute
University of Utah
Memorial Sloan Kettering Cancer Center
NRG Oncology
Institut Bergonié
UNICANCER
University of Cincinnati
Universität Münster
Helsinki University Central Hospital
Sun Yat-sen University
St. Jude Children's Research Hospital
N.N. Petrov National Medical Research Center of Oncology
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Mount Sinai Hospital, Canada
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Centre Leon Berard
University Medical Center Groningen
Karolinska University Hospital
Centre Leon Berard
University Hospital Tuebingen
Children's Cancer Hospital Egypt 57357
Sun Yat-sen University
The Hospital for Sick Children
Wake Forest University Health Sciences
Sheffield Teaching Hospitals NHS Foundation Trust
Barbara Ann Karmanos Cancer Institute
Asan Medical Center
Asan Medical Center
University Hospital Muenster
M.D. Anderson Cancer Center
Institut Claudius Regaud
Gustave Roussy, Cancer Campus, Grand Paris
Impaqtt Foundation
University of Manitoba
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Unity Health Toronto
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Technical University of Munich
Children's Cancer Hospital Egypt 57357
Assistance Publique Hopitaux De Marseille
Central European Cooperative Oncology Group
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of South Florida
Technical University of Munich
Centre Leon Berard